ROLAND C.
- Country
- France
- Department
- Rhumatology
Research Overview
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of AGA2115, a Humanised IgG4 Bispecific Anti‑Sclerostin/DKK1 Antibody, in Adults with Osteogenesis Imperfecta
- A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia
- Efficacy of Transdermal Capsaicin 8% Versus Low-Dose Capsaicin 0.04% in Neuropathic Pain-Associated Digital Osteoarthritis: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 29 of 164 partner sites.
Specializations
Osteoarthritis Research
The investigator specializes in therapeutic approaches for various forms of osteoarthritis, with particular focus on both knee and digital manifestations.
- Knee Osteoarthritis Treatment
- Digital Osteoarthritis Management
- Pain Management Solutions
Exploring innovative therapeutic options including subcutaneous treatments and topical applications for pain relief.
Inflammatory Arthritis
Dedicated to advancing treatment options for rheumatoid arthritis and axial spondyloarthritis, with emphasis on bone erosion prevention.
- Rheumatoid Arthritis Therapeutics
- Axial Spondyloarthritis Management
- Bone Erosion Studies
Investigating advanced imaging techniques and targeted biological therapies for inflammatory conditions.
Metabolic Joint Disorders
Focuses on the treatment of gout with hyperuricemia, evaluating comparative efficacy of various therapeutic approaches.
- Gout Management
- Hyperuricemia Control
- Comparative Treatment Studies
Exploring novel therapeutic agents for optimal uric acid level management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.